Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Inozyme Pharma, Inc. (INZY)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Subramanian Sanjay (SVP, CFO) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Granted 2,319 shares
@ $3.57, valued at
$8.3k
|
|
| 08/03/2023 |
4
| Pivotal bioVenture Partners Fund I, L.P. (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Bought 119,048 shares
@ $4.8, valued at
$571.4k
Bought 714,285 shares
@ $4.8, valued at
$3.4M
|
|
| 08/03/2023 |
4
| Hopfner Robert Lorne (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Bought 119,048 shares
@ $4.8, valued at
$571.4k
Bought 714,285 shares
@ $4.8, valued at
$3.4M
|
|
| 05/15/2023 |
4
| Hopfner Robert Lorne (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Bought 219,230 shares
@ $6.48, valued at
$1.4M
Bought 228,702 shares
@ $6.25, valued at
$1.4M
|
|
| 05/03/2023 |
4
| Bolte Axel (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Granted 100,000 options to buy
@ $5.81, valued at
$581k
|
|
| 04/04/2023 |
4
| Treco Douglas A (CEO) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Granted 800,000 options to buy
@ $0
Granted 100,000 restricted stock units
@ $0 |
|
| 04/04/2023 |
4
| Bolte Axel (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Granted 4,806 shares
@ $2.21, valued at
$10.6k
|
|
| 04/04/2023 |
4
| Subramanian Sanjay (SVP, CFO) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Granted 979 shares
@ $2.21, valued at
$2.2k
|
|
| 04/04/2023 |
4
| Winton Matthew (COO) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Granted 250,000 options to buy
@ $5.39, valued at
$1.3M
|
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2022 |
4
| Bolte Axel (CEO) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Granted 3,315 shares
@ $2.28, valued at
$7.6k
|
|
| 10/04/2022 |
4
| Bjarke Henric Bjorn (SVP, COO) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Granted 3,315 shares
@ $2.28, valued at
$7.6k
|
|
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Sullivan Lynne Marie (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Granted 9,367 options to buy
@ $4.38, valued at
$41k
|
|
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Edwards Martin (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Granted 9,367 options to buy
@ $4.38, valued at
$41k
|
|
| 06/14/2022 |
4
| DIAZ REINALDO M (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Granted 9,367 options to buy
@ $4.38, valued at
$41k
|
|
| 06/14/2022 |
4
| Bhagat Sarah M (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Granted 9,367 options to buy
@ $4.38, valued at
$41k
|
|
| 04/21/2022 |
4
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Bought 1,355,000 shares
@ $3.69, valued at
$5M
|
|
| 04/20/2022 |
4
| Pivotal bioVenture Partners Fund I, L.P. (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Bought 1,070,000 shares
@ $3.69, valued at
$3.9M
|
|
| 04/20/2022 |
4
| Bjarke Henric Bjorn (SVP, COO) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Bought 27,100 shares
@ $3.69, valued at
$100k
|
|
| 04/20/2022 |
4
| Bolte Axel (CEO) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Bought 67,750 shares
@ $3.69, valued at
$250k
|
|
| 04/20/2022 |
4
| Hopfner Robert Lorne (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Bought 1,070,000 shares
@ $3.69, valued at
$3.9M
|
|
| 04/20/2022 |
4
| Subramanian Sanjay (SVP, CFO) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Bought 27,100 shares
@ $3.69, valued at
$100k
|
|
| 03/22/2022 |
4
| Subramanian Sanjay (SVP, CFO) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Granted 180,000 options to buy
@ $3.96, valued at
$712.8k
|
|
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2021 |
4
| Bolte Axel (CEO) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Sold 66,788 shares
@ $0.0001, valued at
$6.7
Exercised 66,788 options to buy
@ $0.98, valued at
$65.5k
|
|
| 06/25/2021 |
4
| Bhagat Sarah M (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Granted 9,367 options to buy
@ $17.12, valued at
$160.4k
|
|
| 06/24/2021 |
4
| Mathers Edward T (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Granted 9,367 options to buy
@ $17.12, valued at
$160.4k
|
|
| 06/24/2021 |
4
| Edwards Martin (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Granted 9,367 options to buy
@ $17.12, valued at
$160.4k
|
|
|
|
|